Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Reported Revenue Growth YoY (%) (%)
Medtronic Form 8-K World-Wide Revenue Tables
Latest, FY2023
-10.1%
Period ended Apr 30, 2023
Change on a year earlier
-3.5 pts
-6.6% in FY2022
History
5 years
Since FY2019
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Reported Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Apr 30, 2023 | -10.1% | -3.5 pts | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | -6.6% | -22.8 pts | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 16.2% | +12.0 pts | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2020 | Apr 30, 2020 | 4.2% | -3081.8 pts | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2019 | Apr 30, 2019 | 3,086.0% | – | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
Cite this data
StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Reported Revenue Growth YoY (%) (%), annual FY2019–FY2023 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-ww-rep
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.